About Pneuma Respiratory
Launched in 2015, Pneuma Respiratory is a pharmaceutical company based in Boone, North Carolina. With a global team of leading researchers, physicians, designers and engineers, Pneuma has created the world's first fully integrated digital soft mist inhaler. Using exclusive digital droplet ejector technology, Pneuma's integrated device has the potential to ultimately deliver a spectrum of novel therapies, including biologics, through the lungs.
Director of Operations: Aaron White
VP, Business Development: James Bauler
Director, High Volume Manufacturing Team: Jacky Li
General Manager, Asia: Huey Wang
Scientific Director: Jack Hebrank, PhD
Droplet Physics Advisor: . Sid Clements, PhD
6 articles with Pneuma Respiratory
Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodies and fusion protein molecules for the pulmonary delivery of Leads' antibodies and molecules.
Pneuma Respiratory, Inc., which has developed PNEUMAHALER™, the first breath-activated digital inhaler (BDI), announced its Board of Directors has elected shareholder J. Knox Singleton to the Board.
Haisco Pharmaceutical Group Co Ltd to Make a $10 Million Equity Investment in Pneuma Respiratory and Enters into a Distribution Agreement
Haisco Pharmaceutical Group is to receive rights to distribute Pneuma Respiratory's pharmaceutical products in China.
Pneuma Respiratory, Inc. has hired Brian Thomas as Project Manager and Kade McNaughton as Controller.
Pneuma Respiratory, Inc. has raised $8.3 million in a Series A financing round.
Pneuma Respiratory, Inc. has recruited Dr. Steven Kesten as President and Chief Medical Officer.